http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0303029-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3482da386a058c42c13cabb954c2d5b5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B64D2010-002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B64D10-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B64D10-00
filingDate 1988-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070b033f8eff8de5615f6227d39e96ca
publicationDate 1989-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0303029-A1
titleOfInvention Pressurising system
abstract In an "anti-g" garment such as a pair of trousers, a pressurising system is provided which consists of a bifurcate bladder (10) and a bifurcate tube (20). Each limb (11, 12) of the bladder (10) extends inside one leg of the trousers, and each limb (21, 22) of the tube (20) extends inside the bladder, at least to the knee and preferably to the calf of the trousers. n Inflation of the bladder (20) therefore takes place from the lower end first, i.e. in a direction opposite to the g- imposed flow of blood of the wearer. This in turn minimises reduction of blood volume in the head of the wearer and raises the "black-out" threshold.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8079970-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387146-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8029450-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8029451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8992449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9205021-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9084713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9114052-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8632840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137052-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8539647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D608006-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D618358-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8721575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8128584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8021388-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8622942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8070699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8740828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8506508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8162861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022076817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8925112-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8109892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364037-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11622883-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8034007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751221-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8016778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012041975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8016779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7442175-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8235923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8597215-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8652079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2255772-A1
priorityDate 1987-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414179477

Total number of triples: 54.